The beta cell in diabetes;Die Rolle der Betazelle im Diabetes mellitus

Deutsche Medizinische Wochenschrift

Volumn 136, Issue 21, 2011, Pages 1123-1127

  Lenzen, S ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

beta cells; diabetes type 1; diabetes type 2; treatment

Indexed keywords

DIABETES MELLITUS; PANCREAS ISLET BETA CELL; REVIEW;

ANTIBODIES; ANTIGENS, CD3; BLOOD GLUCOSE; CELL DEATH; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FATTY ACIDS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; PEROXISOMES; REACTIVE OXYGEN SPECIES; REFERENCE VALUES;

EID: 79956262514     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0031-1280522     Document Type: Review

References (14)

1. Bluestone J A., Auchincloss H, Nepom G T. et al,. The Immune Tolerance Network at 10 years: tolerance research at the bedside. Nat Rev Immunol 2010 10 797-803
2. Cnop M, Welsh N, Jonas J C. et al,. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 2005 54 Suppl 2 S97-107
3. Eisenbarth G S. Type 1 diabetes. Molecular, cellular and clinical immunology. Book. Online Edition version 3.0 ed; http://www.barbaradaviscenter. org/ 2010
4. Eizirik D L., Colli M L., Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nature reviews 2009 5 219-226
5. Elsner M, Gehrmann W, Lenzen S. Peroxisome-generated hydrogen peroxide as important mediator of lipotoxicity in insulin-producing cells. Diabetes 2011 60 200-218
6. Gehrmann W, Elsner M, Lenzen S. Role of metabolically generated reactive oxygen species for lipotoxicity in pancreatic beta-cells. Diabetes, obesity & metabolism 2010 12 Suppl 2 149-158
7. Gurgul E, Lortz S, Tiedge M, Jörns A, Lenzen S. Mitochondrial catalase overexpression protects insulin-producing cells against toxicity of reactive oxygen species and proinflammatory cytokines. Diabetes 2004 53 2271-2280 (Pubitemid 39145580)
8. Jörns A, Günther A, Hedrich H J. et al,. Immune cell infiltration, cytokine expression, and beta-cell apoptosis during the development of type 1 diabetes in the spontaneously diabetic LEW.1AR1/Ztm-iddm rat. Diabetes 2005 54 2041-2052 (Pubitemid 40911267)
9. Leahy J L., Hirsch I B., Peterson K A., Schneider D. Targeting beta-cell function early in the course of therapy for type 2 diabetes mellitus. The Journal of clinical endocrinology and metabolism 2010 95 4206-4216
10. Lenzen S. Oxidative stress: the vulnerable beta-cell. Biochemical Society transactions 2008 36 343-347
11. Rahier J, Guiot Y, Goebbels R M., Sempoux C, Henquin J C. Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes, obesity & metabolism 2008 10 Suppl 4 32-42
12. Schloot N C. Immunintervention zum Betazellerhalt bei Typ-1-Diabetes. Dtsch Med Wochenschr 2010 135 915-921
13. Tiedge M, Lortz S, Drinkgern J, Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 1997 46 1733-1742 (Pubitemid 27456404)
14. Waldhusl W Lenzen S S. Kapitel 14. Kohlenhydratstoffwechsel. In: Schwarz S Förster O Peterlik M Schauenstein K Wick G ed. Pathophysiologie - Molekulare, zellulre, systemische Grundlagen von Erkrankungen. Wien Wilhelm Maudrich Verlag 2007